
Cellebrite DI Ltd.
Cellebrite DI Ltd. (CLBT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CLBT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026Next Earnings Date
EPS & Revenue vs. Estimates
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | $0.06 | — | — | — | $0.13B | — |
| ▼ Q2 FY2026 | May 14, 2026 | $0.08 | $0.04 | -44.5% | $0.13B | $0.13B | +1.0% |
| ▼ Q1 FY2026 | Feb 11, 2026 | $0.14 | $0.09 | -35.7% | $0.13B | $0.13B | +2.1% |
| ▲ Q4 FY2025 | Nov 12, 2025 | $0.09 | $0.14 | +48.2% | $0.13B | $0.12B | +2.5% |
| ▲ Q3 FY2025 | Aug 14, 2025 | $0.10 | $0.12 | +20.0% | $0.11B | $0.11B | +0.9% |
| ▲ Q2 FY2025 | May 14, 2025 | $0.05 | $0.10 | +90.3% | $0.11B | $0.11B | -1.6% |
| — Q1 FY2025 | Feb 13, 2025 | $0.10 | $0.10 | +0.0% | $0.11B | $0.11B | -0.3% |
| ▲ Q4 FY2024 | Nov 6, 2024 | $0.11 | $0.14 | +27.3% | $0.11B | $0.11B | -0.3% |
Analyst Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.14 | $0.15 | $0.15 | 2 |
| Q3 FY2028 | $0.13 | $0.13 | $0.13 | 2 |
| Q2 FY2028 | $0.08 | $0.08 | $0.08 | 2 |
| Q1 FY2028 | $0.08 | $0.09 | $0.09 | 2 |
| Q4 FY2027 | $0.11 | $0.11 | $0.11 | 1 |
| Q3 FY2027 | $0.09 | $0.10 | $0.10 | 1 |
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.2B | $0.2B | $0.2B | 2 |
| Q3 FY2028 | $0.2B | $0.2B | $0.2B | 2 |
| Q2 FY2028 | $0.2B | $0.2B | $0.2B | 2 |
| Q1 FY2028 | $0.2B | $0.2B | $0.2B | 2 |
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 3 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 3 |
Earnings Price Reaction
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -44.5% | $12.10 | $13.12 | +8.43% |
| ▼ Q1 FY2026 | Feb 11, 2026 | -35.7% | $14.94 | $14.26 | -4.55% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +48.2% | $15.70 | $15.97 | +1.72% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +20.0% | $13.99 | $15.29 | +9.29% |
| ▲ Q2 FY2025 | May 14, 2025 | +90.3% | $20.12 | $17.81 | -11.48% |
| ▲ Q1 FY2025 | Feb 13, 2025 | +0.0% | $24.92 | $21.70 | -12.92% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +27.3% | $19.15 | $19.09 | -0.31% |
| ▲ Q3 FY2024 | Aug 15, 2024 | +25.0% | $13.94 | $14.96 | +7.32% |
About Earnings & Data Methodology
Cellebrite DI Ltd. (CLBT) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $0.04 — missing the analyst consensus of $0.08 by -44.5%. The next CLBT earnings date is expected around September 1, 2026.
Each quarter, investors track CLBT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CLBT revenue tab →
Frequently asked questions
CLBT earnings · 5 questionsCellebrite DI Ltd.'s next earnings report is expected around September 1, 2026. CLBT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CLBT historically reports after market close (AMC).
▸ Source: FMP · Cellebrite DI Ltd. SEC filings · US GAAP · Cellebrite DI Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026